Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
ETS transcription factors: possible targets for cancer therapy Oikawa TCancer Sci 2004[Aug]; 95 (8): 626-33Ets family (ETS) transcription factors, characterized by an evolutionally conserved Ets domain, play important roles in cell development, cell differentiation, cell proliferation, apoptosis and tissue remodeling. Most of them are downstream nuclear targets of Ras-MAP kinase signaling, and the deregulation of ETS genes results in the malignant transformation of cells. Several ETS genes are rearranged in human leukemia and Ewing tumors to produce chimeric oncoproteins. Furthermore, the aberrant expression of several ETS genes is often observed in various types of human malignant tumors. Considering that some ETS transcription factors are involved in malignant transformation and tumor progression, including invasion, metastasis and neo-angiogenesis through the activation of cancer-related genes, they could be potential molecular targets for selective cancer therapy.|Cell Transformation, Neoplastic[MESH]|Humans[MESH]|Leukemia[MESH]|Lymphoma[MESH]|Neoplasm Invasiveness[MESH]|Neoplasm Metastasis[MESH]|Neoplasms/*physiopathology/*therapy[MESH]|Neovascularization, Pathologic[MESH]|Prognosis[MESH]|Proto-Oncogene Proteins c-ets[MESH]|Proto-Oncogene Proteins/*biosynthesis/*genetics/pharmacology[MESH]|Signal Transduction[MESH]|Transcription Factors/*biosynthesis/*genetics/pharmacology[MESH] |
